Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

NCT01936233 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2019-08-05

No results posted yet for this study

Summary

Evaluation the Treatment Outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.

Conditions

Interventions

DRUG

Aspirin

Aspirin 0.1 QD po

DRUG

Lamivudine

LAminvudine 0.1 QD po

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Zhenggang Ren, Ph.D · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01936233 on ClinicalTrials.gov